Literature DB >> 1249417

Characterization of the target cell receptor for IgE. II. Polyacrylamide gel analysis of the surface IgE receptor from normal rat mast cells and from rat basophilic leukemia cells.

D H Conrad, A Froese.   

Abstract

Purified rat peritoneal mast cells (RMC) and cultured rat basophilic leukemia (RBL) cells were surface labeled with 125I by using lactoperoxidase, incubated with unlabeled rat monoclonal IgE and subjected to solubilization by treatment with Nonidet P-40 (NP-40). With both cell types significant amounts of radioiodinated material could be specifically precipitated by a "sandwich" system consisting of rabbit anti-rat epsilon-chain and goat anti-rabbit Ig. The precipitates were dissociated with sodium dodecyl sulfate (SDS) and urea and subsequently analyzed by SDS-polyacrylamide gel electrophoresis. With RMC three radioactive bands were seen. One corresponded to IgE present on the RMC at the time of isolation. A small band migrating in the region of light chain was seen with both sepcific (anti-IgE) and control precipitates. It showed no demonstrable relationship to IgE. The major radioactive band corresponded to a m.w. of 62,000. This band was dependent upon the presence of IgE and was not found when non-IgE binding control cells were used. With RBL cells, only the IgE-dependent 62,000 dalton peak was present. Saturation of the IgE receptor sites of the RMC or RBL cells before lactoperoxidase labeling almost totally eliminated this radioactive band, indicating that cell-bound IgE rendered this membrane component inaccessible to the radiolabel. These results strongly suggest that this cellular component is identical, at least in part, with the target cell surface receptor for reaginic antibody. The data also further support the hypothesis that the neoplastic RBL cells have a normal surface receptor for IgE.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1249417

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Biochemical identification of glycosylation inhibiting factor.

Authors:  K Katamura; M Iwata; A Mori; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 2.  The receptor for the Fc region of IgE.

Authors:  A D Keegan; D H Conrad
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Identification of an IgE-binding protein by molecular cloning.

Authors:  F T Liu; K Albrandt; E Mendel; A Kulczycki; N K Orida
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

Review 4.  Anaesthesia and allergic drug reactions.

Authors:  G C Moudgil
Journal:  Can Anaesth Soc J       Date:  1986-05

5.  The incorporation of tritiated precursors into receptors for IgE of rat basophilic leukemia cells.

Authors:  R M Helm; A Froese
Journal:  Immunology       Date:  1981-04       Impact factor: 7.397

Review 6.  Mechanisms of reaginic hypersensitivity and immunotherapy.

Authors:  K Ishizaka; T Ishizaka
Journal:  Lung       Date:  1978       Impact factor: 2.584

7.  Comparison of the receptors for IgE of various rat basophilic leukaemia cell lines. I. Receptors isolated by IgE-sepharose and IgE and anti-IgE.

Authors:  A Froese; R M Helm; D H Conrad; C Isersky; T Ishizaka; A Kulczycki
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

8.  Selective phosphorylation of the IgE receptor in antigen-stimulated rat mast cells.

Authors:  B L Hempstead; C W Parker; A Kulczycki
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

9.  Isolation and partial characterization of Fc gamma-binding proteins of human leukocytes.

Authors:  A Kulczycki; L Solanki; L Cohen
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

10.  Molecular weight and valence of the cell-surface receptor for immunoglobulin E.

Authors:  S A Newman; G Rossi; H Metzger
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.